Landers John, Tan Teng-Han, Yuen Joshua, Liu Henry
Orana Eye Centre, Dubbo, New South Wales, Australia.
Clin Exp Ophthalmol. 2007 Mar;35(2):152-9. doi: 10.1111/j.1442-9071.2006.01434.x.
Recently an intraocular lens (IOL) has been introduced which blocks blue light. As blocking blue light may be to the patient's detriment, this study was designed to evaluate visual function following implantation of a blue-blocking (Acrysof Natural) IOL.
Patients were recruited for this non-randomized controlled interventional study, from those attending a private rural ophthalmology clinic for cataract surgery (n = 93). Only those who had previously had a conventional IOL implanted into one eye were offered an Acrysof Natural IOL for the second eye. Postoperatively patients underwent refracted Snellen visual acuity, contrast sensitivity using a CSV-1000E instrument and colour vision testing using a Farnsworth D-15 test, with a subset (n = 20) undergoing a Farnsworth-Munsell 100-Hue test. Results were then compared between eyes. Finally, a subset (n = 63) completed a survey designed to assess the subjective impact of the Acrysof Natural IOL.
There were no statistically significant differences between eyes implanted with conventional IOLs compared with Acrysof Natural IOLs for visual acuity (t = 0.57; P = 0.57), contrast sensitivity (t = 0.43; P = 0.67 for 3 cycles per degree [cpd], t = 0.56; P = 0.58 for 6 cpd, t = 0.09; P = 0.93 for 12 cpd and t = 0.16; P = 0.87 for 18 cpd) or colour vision with the Farnsworth D-15 (Chi(2) = 0.38; P = 0.55) or the Farnsworth-Munsell 100-Hue test t = 0.34; P = 0.74). Most subjects reported that they could not tell a difference between the two IOLs subjectively or that any difference experienced was not significant.
Our sample did not show any significant differences between eyes implanted with conventional IOLs and the Acrysof Natural IOL. We would suggest that the Acrysof Natural IOL may be used without any significant difference in visual function.
最近推出了一种可阻挡蓝光的人工晶状体(IOL)。由于阻挡蓝光可能对患者有害,本研究旨在评估植入蓝光阻挡型(Acrysof Natural)人工晶状体后的视觉功能。
本非随机对照干预性研究招募了在一家农村私立眼科诊所接受白内障手术的患者(n = 93)。仅那些先前已在一只眼中植入传统人工晶状体的患者被提供Acrysof Natural人工晶状体用于另一只眼。术后患者接受了矫正的斯内伦视力检查、使用CSV - 1000E仪器进行的对比敏感度测试以及使用法恩斯沃思D - 15测试进行的色觉测试,其中一部分患者(n = 20)还进行了法恩斯沃思 - 芒塞尔100色调测试。然后对双眼的结果进行比较。最后,一部分患者(n = 63)完成了一项旨在评估Acrysof Natural人工晶状体主观影响的调查。
植入传统人工晶状体的眼睛与植入Acrysof Natural人工晶状体的眼睛在视力(t = 0.57;P = 0.57)、对比敏感度(每度3周波[cpd]时t = 0.43;P = 0.67,6 cpd时t = 0.56;P = 0.58,12 cpd时t = 0.09;P = 0.93,18 cpd时t = 0.16;P = 0.87)或使用法恩斯沃思D - 15进行的色觉测试(χ² = 0.38;P = 0.55)或法恩斯沃思 - 芒塞尔100色调测试(t = 0.34;P = 0.74)方面均无统计学显著差异。大多数受试者报告称,他们主观上无法分辨两种人工晶状体之间的差异,或者所体验到的任何差异都不显著。
我们的样本未显示植入传统人工晶状体的眼睛与植入Acrysof Natural人工晶状体的眼睛之间存在任何显著差异。我们建议可以使用Acrysof Natural人工晶状体,且视觉功能不会有任何显著差异。